Healthcare, biotechnology & medical AI Product
VUNO Med-DeepBrain measures structures on brain MRI
VUNO Med-DeepBrain automatically labels and quantifies structures visible on brain MRI and displays the results for professional review. [1]
- Release status
- U.S. FDA 510(k) clearance K231398, decided October 4, 2023. [1]
What it does
The FDA cleared the named software on October 4, 2023, under 510(k) K231398 as a Class II medical image management and processing system. [1]
Why it matters
The software automates the production of structural measurements that would otherwise require manual identification and labeling. [1]
Who it’s for
The published use concerns healthcare professionals who review structural brain MRI. [1]
Key dates
- FDA clears VUNO Med-DeepBrain [1]
Where it fits
The output combines labels and quantitative information with visualizations of the structures it can segment. [1]
Limits and trade-offs
The FDA filing describes an image-processing function and its defined outputs. It does not establish a disease-specific diagnosis claim. [1]
Sources and verification
Catalog evidence checked How we verify records
- Primary source FDA 510(k) decision for VUNO Med-DeepBrain (K231398)
Related profiles
Healthcare, biotechnology & medical AI
Sleep Analysis Module (SAM)
Neurotronics (Nihon Kohden)
The module estimates sleep time from a signal captured during its intended sleep-testing workflow.
Healthcare, biotechnology & medical AI
Heartvue.Proton
Heartvue.ai
It is software for analyzing cardiac MRI images within its documented intended-use scope.
Healthcare, biotechnology & medical AI
ThinkSono Guidance
ThinkSono
Provides guidance during acquisition of lower-extremity compression ultrasound images for review by healthcare professionals.